Activity of Seviteronel in Patients With Androgen Receptor (AR)-Positive Glioblastoma
Clinical trial NCT03600467 · TERMINATED
Trial details
- NCT number
- NCT03600467
- Sponsor
- St Vincent's Hospital, Sydney
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-13
- Primary completion
- 2021-02-28
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.